Regulatory change in Canada’s provinces, and the lack of it at federal level in the US, are both encouraging innovation by providers of financial services to cannabis businesses
A Swiss CBD company has questioned the approach of European authorities in demanding further data in order to advance novel food applications, describing it as an issue that might signal the end of hemp-extracted cannabinoids as a viable sector in the EU
Patients in Spain will soon be able to access cannabis in pharmacies with a medical prescription as the government is about to introduce new legislation
This report offers a detailed summary of the current regulatory framework in place for CBD, hemp and cannabis in Luxembourg. It covers everything from hemp cultivation and processing, to finished products and extracts, and the country’s medical and recreational cannabis policies
The Argentine hemp industry is hopeful that sales of delta-8 THC hemp products will be formally permitted under the country’s new legal framework for cannabinoids
This snapshot of the UK’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Hemp producers have lost an important challenge on the 0.3% THC threshold for hemp-derived products in the US, potentially making producers liable if they go over the threshold during production, whether or not the end product meets the limitation
There is quite a bit of baggage in how reference is made to the Cannabis sativa plant – as demonstrated by what’s behind a new change to the law in the US state of Washington
Colombian president-elect Gustavo Petro says he will prioritise development of the nation’s cannabis industry and is promising that he will improve regulation, expand the existing legal framework and clarify production regulation as well as decriminalise consumption
This report offers a detailed summary of the current regulatory framework in place for CBD, hemp and cannabis in Austria. It covers everything from hemp cultivation and processing, to finished products and extracts, and the country’s medical and recreational cannabis policies
This report seeks to outline the substance of the discussion at the EU level about the use of CBD and other hemp ingredients in cosmetic products, gleaned from documents CBD-Intel has obtained from EU authorities that show input provided by some member states on the matter, as requested by the European Commission
It looks like there will be no easy or quick solutions to addressing the data gaps the European Food Safety Authority (EFSA) requires to reach a conclusion on the safety of CBD as an ingestible ingredient
This report offers a detailed overview of Japan’s regulatory regime for cannabis, CBD and hemp, covering all policy areas and discussing future changes to the law
The European Food Safety Authority wants more safety data before it approves CBD products as novel food. This is what it wants to know, and why, along with a summary of the science on each point
A bid to legalise recreational cannabis in the US state of Delaware failed when lawmakers fell just short in a rare bid to overturn a governor’s veto